From CEA to BCA: Values and decisions
As part of the Anne Mills Health Economics Lecture series, this lecture will compare the similarities and differences between cost-effectiveness analysis (CEA) and benefit-cost analyses (BCA).
Any form of economic evaluation requires normative judgements about how to define value. For health and longevity, cost-effectiveness analysis (CEA) relies on non-monetary measures, particularly quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs), while benefit-cost analysis (BCA) relies on monetary estimates of willingness to pay (WTP). This presentation will focus on the similarities and differences between these types of analysis, including the relationship between the monetary thresholds used in CEA and the WTP estimates used in BCA.
This lecture, hosted by the Global Health Economics Centre, is part of the Anne Mills Health Economics Lecture series. Each year, the Centre invites a health economist to present a lecture on a key topic of the field. The speaker’s presentation will be followed by a reception where all attendees are welcome in the Pumphandle Social: Café and Courtyard.
The series has been named in honour of Professor Dame Anne Mills, a towering figure in health economics whose four decades-plus tenure at LSHTM has had an immeasurable impact both at the School and in the field.
Speaker
Lisa A. Robinson
Lisa A. Robinson serves as Deputy Director of the Center for Health Decision Science (CHDS) and as core faculty of the Center for Climate, Health, and the Global Environment (C-CHANGE) at the Harvard T.H. Chan School of Public Health.
Her research and teaching focus on the improving the use and usefulness of benefit-cost analysis and other forms of economic evaluation. She has led many assessments of the costs, benefits, and other impacts of interventions that aim to improve health, developed related methods, and drafted guidance documents. Her work explores numerous methodological issues, such as the approaches used to value mortality and morbidity risks reductions (including the value per statistical life - VSL); the relationship between estimates of individual willingness to pay and the thresholds used in cost-effectiveness analyses; and the assessment of distributional equity. She applies these methods in high-, middle-, and low-income settings.
Event notices
- Please note that you can join this event in person or you can join the session remotely
- Please note that the recording link will be listed on this page when available
Admission
Contact
